Yang Fangjiu, Zhang Xiaoming, Xie Xiadan, Yang Shengbo, Xu Yan, Xie Peng
Department of Anatomy, Zunyi Medical University Zunyi, Guizhou, People's Republic of China.
Department of Anatomy and Cell Biology, University of Kansas Medical Center Kansas, KS 66160, USA.
Am J Transl Res. 2016 Dec 15;8(12):5485-5493. eCollection 2016.
Botulinum toxin (BoNT) can relieve muscle spasticity by blocking axon terminals acetylcholine release at the motor endplate (MEP) and is the safest and most effective agent for the treatment of muscle spasticity in children with cerebral palsy. In order to achieve maximum effect with minimum effective dose of BoNT, one needs to choose an injection site as near to the MEP zone as possible. This requires a detailed understanding about the nerve terminal distributions within the muscles targeted for BoNT injection. This study focuses on BoNT treatment in children with muscle spasms caused by cerebral palsy. Considering the differences between children and adults in anatomy, we used child cadavers and measured both the nerve entry points and nerve terminal sense zones in three deep muscles of the anterior forearm: flexor digitorum profundus (FDP), flexor pollicis longus (FPL), and pronator quadratus (PQ). We measured the nerve entry points by using the forearm midline as a reference and demonstrated intramuscular nerve terminal dense zones by using a modified Sihler's nerve staining technique. The locations of the nerve entry points and that of the nerve terminal dense zones in the muscles were compared. We found that all nerve entry points are away from the corresponding intramuscular nerve terminal dense zones. Simply selecting nerve entry points as the sites for BoNT injection may not be an optimal choice for best effects in blocking muscle spasm. We propose that the location of the nerve terminal dense zones in each individual muscle should be used as the optimal target sites for BoNT injection when treating muscle spasms in children with cerebral palsy.
肉毒杆菌毒素(BoNT)可通过阻断运动终板(MEP)处轴突末端乙酰胆碱的释放来缓解肌肉痉挛,是治疗脑瘫患儿肌肉痉挛最安全、最有效的药物。为了以最小有效剂量的BoNT达到最大效果,需要选择尽可能靠近MEP区域的注射部位。这需要详细了解BoNT注射靶向肌肉内的神经末梢分布情况。本研究聚焦于BoNT治疗脑瘫引起的肌肉痉挛患儿。考虑到儿童与成人在解剖学上的差异,我们使用儿童尸体,测量了前臂前侧三块深层肌肉:指深屈肌(FDP)、拇长屈肌(FPL)和旋前方肌(PQ)的神经入点和神经末梢感觉区。我们以前臂中线为参照测量神经入点,并使用改良的席勒神经染色技术显示肌肉内神经末梢密集区。比较了肌肉中神经入点和神经末梢密集区的位置。我们发现所有神经入点均远离相应的肌肉内神经末梢密集区。单纯选择神经入点作为BoNT注射部位可能并非阻断肌肉痉挛最佳效果的最佳选择。我们建议,在治疗脑瘫患儿肌肉痉挛时,应将每块肌肉中神经末梢密集区的位置作为BoNT注射的最佳靶点。